- Open Access
Rationale, bench testing and in vivo evaluation of a novel 5 mm laparoscopic vessel sealing device with homogeneous pressure distribution in long instrument jaws
© Eick et al.; licensee BioMed Central Ltd. 2013
- Received: 26 June 2013
- Accepted: 3 December 2013
- Published: 10 December 2013
In 1998, an electrothermal bipolar vessel sealing (EBVS) system was introduced and quickly became an integral component of the surgical armamentarium in various surgical specialties. Currently available EBVS instruments use a scissor-like jaw configuration and closing mechanism, which causes decreasing compression pressure from the proximal to the distal end of the jaws. A new EBVS system is described here which utilizes a different instrument jaw configuration and closing mechanism to enable a more homogeneous pressure distribution despite longer instrument jaws.
Results of jaw pressure distribution measurements as well as sealing experiments with subsequent burst pressure measurements ex vivo on bovine uterine arteries are demonstrated. Furthermore, an in vivo evaluation of the new EBVS system in a canine and porcine model including histological examination is presented.
The device revealed an even pressure distribution throughout the whole jaw length. The ex vivo burst pressure measurements revealed high average burst pressures, above 300 mmHg, independent of the outer diameter (1 to 7 mm) of the tested vessels. Histological evaluation of sealed vessels 21 days postoperatively demonstrated sealed and fused vessels without adjacent tissue damage.
The even pressure distribution leading to a sufficient tissue sealing in combination with the novel closing mechanism and extended jaw length differentiates the novel device from other available EBVS systems. This might offer a reduction of the overall procedure time, which should be further evaluated in a clinical study.
- Surgical instruments
- Tissue sealing
- Laparoscopic surgery
- Thermal injury
- Burst pressure
- Equipment design
Since the introduction of an electrothermal bipolar vessel sealing (EBVS) system in 1998 and initial reports of its clinical usage, this technology has evolved to a standard method for sealing and transecting blood vessels [1, 2]. Today, EBVS systems are offered by various manufacturers and widely used in several surgical specialties such as general and visceral surgery [1, 3, 4], gynecology [5, 6], urology [2, 7], cardio-thoracic , and pediatric surgery [7, 9]. Recent systematic reviews and meta-analyses of randomized controlled clinical trials [10–12] revealed that EBVS systems are safe and at least equally effective concerning blood loss and operating time in comparison to ultrasonic energy devices for blood vessel transection in abdominal surgery.
Besides providing electrothermal energy via a feedback-controlled electrosurgical process, it is equally important for good seal stability and reliable sealing quality to apply sufficient mechanical force to the tissue, as already pointed out in early research articles . Therefore, exact controlling of the compressive force within the instrument is considered as highly important and a well-defined and homogeneous tissue compression throughout the whole length of the instrument jaws is desirable [14, 15].
Currently available EBVS instruments use a scissor-like jaw configuration and closing mechanism, which causes decreasing compression pressure from the proximal to the distal end of the jaws. Thus, a possible weakness in the sealing quality can be found at the tip of the instrument, especially when the jaws are completely filled with tissue during the sealing process. The longer the jaws of such a scissor-like instrument are, the more pronounced is this effect. This especially limits the maximum length of the jaws and the sealing electrodes of scissor-like laparoscopic instruments with a diameter of 5 mm.
Because of these effects of uneven pressure distribution and limited electrode length as well as manufacturers focus in the development of the sealing process on speed, surgeons might be accustomed to employing multiple energy activation cycles to seal bigger arteries for a higher confidence in the seal stability. Consecutive sealing procedures next to each other or even at the same position before activating the cutting mechanism of the device is called “double seal” or “overlapping seal”; however, this has only been published rarely in the scientific literature and can sometimes only be evaluated in published videos [16–18].
The aim of the given article is to report on a new EBVS system with focus on a 5 mm laparoscopic vessel sealing instrument, which utilizes a different instrument jaw configuration and closing mechanism to enable a more homogeneous pressure distribution despite longer instrument jaws in comparison to other known vessel sealing instruments. In detail, the jaw configuration and results of jaw pressure distribution measurements as well as sealing experiments with subsequent burst pressure measurements ex vivo on bovine uterine arteries are demonstrated. Finally, an in vivo evaluation of the new EBVS system in a canine and porcine model including histological examination is presented.
Vessel sealing system
The new EBVS system evaluated in this study is a bipolar electrosurgical system and consists of the Lektrafuse RF generator and the laparoscopic Caiman® 5 instrument (Aesculap AG, Tuttlingen, Germany). The RF Generator is capable of delivering an AC power of 150 W in an impedance range between 10 and 90 Ohms. The instrument-specific feedback-controlled sealing algorithm is primarily optimized for seal quality and safety and is automatically selected, when the instrument is attached to the generator.
Instrument jaws and closing mechanism
This closing mechanism should avoid that any tissue is being pushed out of the jaws during closing, and enables a parallel jaw alignment with varying thickness of tissue and thus an even pressure distribution and tissue compression within the jaws. In the final configuration, the user enables the sealing process by pushing the activation button one time and the vessels and/or connective tissues are sealed and finally cut mechanically by the surgeon. Due to the closing mechanism and the even tissue compression throughout the whole length of the instrument jaws, the jaws and the sealing electrodes can be longer than in other 5 mm laparoscopic vessel sealing instruments with scissor-like jaws, resulting in a superior sealing length of 26,5 mm.
Jaw pressure measurements
To measure the distribution and amount of pressure within the jaws of the Caiman® 5 instrument, a pressure measurement system (Tekscan, Inc., South Boston, MA, USA) was utilized. For comparison, the jaw pressure was also measured for two conventional vessel sealing instruments: the Covidien LigaSure™ 5 mm and the Covidien LigaSure Advance™ (Covidien Surgical Solutions Group, Boulder, CO). All measurements were made with the same measurement setup and measurement procedure described in this section.
The pressure measurement system consist of a Tekscan 5027 Sensor, which is clamped into the EH-2 Tekscan handle and connected to a personal computer with I-Scan® lite software. The sensor and measurement system were calibrated for two points within the range of force expected (roughly 1.1 MPa) and equilibrated for the study per standard operation procedure and according to manufacturer‘s recommendation.
To simulate the tissue layers, which are compressed within the instrument jaws, a piece (roughly 4 cm by 4 cm) of a 0.5 mm thick compressible silicone pad (50A durometer silicone rubber pad #3788 T21; McMaster-Carr®, Elmhurst, IL) was placed on either side of the pressure sensor. To ensure an accurate force reading, the silicone was placed even with or just inside of the sensors footprint where the jaws are clamped onto the sensor. The sensor with the silicone pads was fully inserted into the jaws of the instrument and the jaw set was closed. The sensor reading was stabilized for approximately two seconds and recorded.
Burst pressure measurements
To evaluate the initial sealing quality and reliability of the EBVS system, burst pressure measurements on sealed explanted arteries of various diameters were utilized. The standardized burst pressure measurements were conducted with a laboratory burst pressure measurement system based on a digital gear pump (pump head model #07002-25; gear pump drive model #75211-30; Cole-Parmer, Court Vernon Hills, IL, USA;) as described in the following: the untreated bovine uterine arteries, sized approximately 1 to 7 mm in outer diameter (OD), were freshly frozen directly after harvesting. Before the experiments, the frozen tissue was allowed to thaw to approximately room temperature, bagged and placed in warm water until it had reached approximately 37°C. Testing was performed with tissue temperatures between 25°C (room temperature) and 37°C (body temperature).
Three different size classes of arteries were defined according to their OD when laying approximately flat across a finger: small (1–2 mm), medium (2–4 mm), and large (4–7 mm). The tissue samples were inspected to locate an artery with an OD in the desired size range for sealing and also inspected to assure that the vessels were not cut or damaged in any way. If the artery was encapsulated in connective tissue it was not separated from the tissue.
After confirming the tissue was moist, the artery was clamped with the Caiman® 5 instrument and the sealing was performed by activating the Lektrafuse RF generator once. After completion of the sealing, the arteries were divided using the cutting mechanism on the instrument. Then, the non-sealed end of each artery was slipped on to the appropriate sized dispensing needle attached to the vessel burst pressure measurement system and the artery was secured mechanically onto the needle with hemostats with conformal tubing on each jaw to assure no retrograde leakage. It was mandatory to have at least 5 mm between the seal and the needle.
Burst pressure measurement was started by pumping water into the artery with a flow rate of 15 or 47 ml/min depending on needle diameter. If any leaks were observed along the needle/artery attachment or anywhere along the artery (other than at the sealed end), those leaks were clamped. The maximum pressure was recorded once the artery wall leaked or the sealed end burst. Arteries that were damaged during test set up were not further evaluated.
There is no clear standard given in the literature for a required burst pressure measurement for separating a successful artery seal from a failure. Published values strongly vary from 50 mmHg , 150 mmHg , 250 mmHg , 300 mmHg [20–22], 360 mmHg , up to 400 mmHg . Nevertheless, burst pressure provides a reproducible stability index of the seal. We chose 300 mmHg or 2.5 times of the average systolic artery pressure as requirement for a successful seal, suggesting this will be safe under systolic pressure in normal patients or those with treated hypertension.
Animal tests with blood vessel sealing were performed to prove the sufficiency of the vessel sealing system’s capabilities in vivo as well as to evaluate acute and chronic survival of the animals. Furthermore, the sealed tissues were evaluated macroscopically and histologically.
The animal studies were designed as regulatory study required by the FDA for device clearance and were performed at BioSurg, Inc. animal facility (Winters, CA, USA). BioSurg is a certified Class R Research Facility under the Animal Welfare Act (7 U.S.C. 2131 et seq., Certificate No. 93-R-0200, Customer No. 1139) and maintains an Animal Welfare Assurance (No. A3751-01) by the Office of Laboratory Animal Welfare (OLAW) that was submitted in compliance with the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals. The Institutional Animal Care and Use Committee (IACUC) reviewed and approved all activities involving the use of live "covered" animals within this study prior to their initiation (Protocol No. SA0908n).
Overall, the experiments were performed on three dogs and one pig. The Caiman® 5 was used to seal and divide mesenteric and parametrial tissues and structures surrounding the targeted organs. For every transaction site, the seal process was only activated once. To demonstrate substantial equivalence, another dog was operated on using the predicate, conventional EBVS system (LigaSure™ 5 mm instrument and ForceTriad™ Energy Platform, Covidien). The animals were examined acutely for vessel sealing and were then survived chronically for 21 days. Each animal was positioned in dorsal recumbency, anesthetized and surgically prepped and draped according to BioSurg’s standard operating procedures. A BioSurg Veterinary surgeon performed the operative procedures using sterile technique throughout all procedures.
In the three dogs, various surgical procedures including left nephrectomy, ovariohysterectomy and splenectomy were performed with the Caiman® 5. In the comparative dog, a splenectomy and nephrectomy were performed with the conventional EBVS system. In the pig, the left carotid artery was transected using the Caiman® 5. Several treated vascular segments were removed acutely and preserved in 10% Neutral Buffered Formalin (NBF) for histologic analysis at a later date. After the sealed tissues had been examined for adequate hemostasis, the abdomen was closed and each animal recovered as per BioSurg’s anesthesia and surgical SOPs. The animals were survived post operatively for a period of 21 days.
After 21 days, the animals were sacrificed and a necropsy was performed on each animal with emphasis on identifying the treatment sites. During necropsy, evidence of mechanical or thermal injury to adjacent tissue structures and recent or active bleeding from treatment sites was assessed. Chronic treatment sites were photographed, excised en bloc, and immersion fixed in 10% NBF. All transected vascular segments (acute and chronic) were trimmed and routinely processed for histopathologic processing and microscopic analysis. Briefly, tissues were dehydrated in a series of graded alcohol solutions, cleared in xylene, embedded in paraffin, sectioned at 4–6 microns, and stained with hematoxylin and eosin (H&E) for light microscopic evaluation. Acute and chronic histology were compared to assess efficacy/safety concerns that could be related to vessel leakage at the occlusion site due to thermal injury and possible tissue necrosis.
Jaw pressure distribution measurement
While the hinged jaw of the Caiman® 5 enables an even pressure distribution in a range between roughly 0.6 and 1.2 MPa throughout the whole jaw length with only a slight medial maximum, the other two sealing devices show an uneven pressure distribution. The pressure strongly decreases from more than 1.4 MPa at the proximal jaw end to virtually zero at the distal tip and within the last quarter of the jaw length. Figure 3 also shows the jaws and the sealing electrodes of the Caiman® 5 are longer in comparison to the jaws and electrodes of the conventional sealing devices.
Burst pressure measurements
Burst pressure measurements
OD small (n = 85)
OD medium (n = 92)
OD large (n = 95)
Mean ± SD
1.9 ± 0.3
1015 ± 536
3.3 ± 0.6
1017 ± 514
5.2 ± 0.9
865 ± 389
Min / max
1.0 / 2.0
131 / 2975
2.0 / 4.0
304 / 2428
4.0 / 7.0
313 / 2288
BP < 300 (n)
For all three size classes of arteries (OD small, OD medium, and OD large), the burst pressure measurements showed high average burst pressures of roughly 3 times the minimum requirement. Out of all 272 measurements, only for one artery (size OD small, burst pressure 131 mmHg), the minimum burst pressure was not reached.
Altogether, 70 blood vessel and tissue seals, including 38 arteries with outer diameters between 1 and 8 mm (3.0 ± 2.3 mm; mean ± SD) and 28 non-arterial vessels with outer diameters between 1 and 10 mm (3.0 ± 2.5 mm), were performed within the three dogs and one pig. Each site was transected with a single activation of the sealing process and subsequent cutting.
For all 70 seals, no acute seal failure was observed. The average seal duration was 3.9 ± 1.1 s (min: 1.8 s, max: 6.4 s). The average measured thermal spread beyond the instrument jaws was less than 1 mm. No arcing and charring and only minor tissue adhesion occurred. All four animals survived for 21 days with no postoperative complications and acceptable animal stress. After 21 days, the reoperation (necropsy) was performed, showing no chronic seal failures and no mechanical or thermal injury in the treatment sites for all animals.
After 21 days, gross assessment showed healed treatment sites with no indication of recent or active bleeding and of adjacent tissue or organ damage. Microscopically, the treated arterial segments all demonstrated occlusive thrombosis at the transected ends with a surrounding cap of organized fibrotic tissue. The luminal thrombus was typically organized with sprouting of endothelial cells and fibroblasts forming interconnected microvascular channels and focally lympho-histiocytic inflammatory cells. Figure 4 (C,D) shows representative photomicrographs of H&E sections stained in “chronic stage” as examples.
The remaining transected ends of the arteries demonstrated both coagulative thermal necrosis (a result of the initial treatment) and lytic necrotic change (a result of the subsequent inflammatory process). The surrounding fibrous cap was minimally inflamed with lymphocytes and histiocytic cells. Xanthogranulomatous changes, often with scant mineralized centers, were also scattered in the vicinity in the surrounding adherent fat and nerve bundles.
All acute and chronic histopathologic tissue changes were similar to those found in the comparative fourth dog, which was operated on with the conventional blood vessel sealing system.
The transection site of the carotid artery was identified grossly and was surrounded by fibrous adhesion. There was no evidence of recent or on-going bleeding. Proximal and distal sections of the carotid artery were evaluated microscopically.
Similar to the canine samples, there was an occlusive luminal thrombus in both segments, which was organized by fibroblasts and contained pockets of fibrin or blood. Organized fibrovascular tissue capped both the proximal and distal ends. A minimal degree of lymphohistiocytic inflammation was present throughout.
Strongly driven by the increasing percentage of minimally invasive surgical procedures, more advanced electrosurgical instruments with the ability to transect tissues and seal vessels became a standard in various fields of surgery, since their introduction just more than a decade ago. The instruments undergo a steady development, as surgeons demand them for more and more complex procedures, such as liver and pancreatic resections [25, 26].
In particular an increased jaw length with equally distributed closing pressures and a safe closing mechanism starting at the tip of the device were the demands when the development of the new device started. Due to the laws of mechanics, every scissor-like instrument produces an uneven pressure distribution between the jaws when grasping tissue. The uneven pressure distribution is more pronounced as the tissue thickness between the jaws is increased. For blood vessel sealing instruments, it is well known that sealing process and sealing quality strongly depend on the pressure [14, 15]. Therefore, every scissor-like sealing instrument produces uneven sealing quality due to strong pressure variations from the proximal to the distal end of the jaws. Especially at the tip of the instrument, a satisfactory sealing quality cannot be guaranteed, when the jaw of the instrument is completely filled with tissue. Due to the hinged jaw, the Caiman® 5 instrument shows an even pressure distribution with only a slight maximum at the middle of the jaw length, as could be shown with pressure measurements in the instrument jaws.
Because of the even pressure distribution in hinged jaws, it was possible to construct the Caiman® 5 instrument with long jaws with 26,5 mm of sealing length, which is one third longer than other available vessel sealing instruments on the market. This allows the sealing of more tissue with one bite than with other instruments. In combination with an optimized sealing process, the instrument allows for constant sealing quality throughout the whole length of the instrument jaws with a single activation of the sealing process, as was shown with successful sealing experiments both ex vivo and in vivo.
On explanted bovine arteries, the burst pressure measurements showed reliable sealing results with average burst pressures of roughly three times the minimum requirement for all three evaluated size classes of arteries. Those results are in the same range or even better than reported values in the literature [8, 14, 15, 19–24] and demonstrate the reproducibility of a high initial stability of artery seals with the new EBVS system using the Caiman® 5 instrument.
In a canine and a porcine animal model, the acute and chronic stability and healing of artery seals with the novel instrument was evaluated and compared to seals with a conventional system in vivo. The gross and histological findings were similar in all animals at each site. There was no evidence of recent or active bleeding at any of the transection sites, including the left carotid artery in the porcine animal model, showing reliability of the Caiman® 5 instrument even for sealing of large blood vessels.
Quality and reliability of blood vessel sealing strongly depends on the pressure in the instrument’s jaws. Scissor-like instruments show strong pressure variations from the proximal to the distal end of the jaws, potentially leading to uneven sealing quality with possible weaknesses at the tip of the instrument. Utilizing an additional hinge in the lower instrument jaw, the Caiman® 5 instrument establishes an even pressure distribution within the instrument’s jaws, which are longer than other 5 mm laparoscopic blood vessel sealing instruments’ jaws. As shown ex vivo and in vivo, the system enables acute seal stability with a single process activation and chronic healing of blood vessel transaction sites. The evaluated EBVS system offers a constant level of confidence in seal quality (safe hemostasis with one seal) in the tested setup and, in combination with the longer instrument jaws, the prospective of a reduced overall procedure duration, which should be evaluated in a clinical trial.
The authors would like to acknowledge Cindy Nguyen for support in data acquisition, Markus Bauer for support in literature research and discussions during the preparation of the manuscript, and Theodor Lutze for overall support of the development process of the described new EBVS system.
- Heniford BT, Matthews BD, Sing RF, Backus C, Pratt B, Greene FL: Initial results with an electrothermal bipolar vessel sealer. Surg Endosc 2001,15(8):799–801. 10.1007/s004640080025PubMedView ArticleGoogle Scholar
- Sengupta S, Webb DR: Use of a computer-controlled bipolar diathermy system in radical prostatectomies and other open urological surgery. ANZ J Surg 2001,71(9):538–540. 10.1046/j.1440-1622.2001.02186.xPubMedView ArticleGoogle Scholar
- Minner S, Rödiger H, Mansmann U, Böhm B: [Randomized controlled trial on vessel sealing in thyroid surgery]. Zentralbl Chir. 2007,132(5):446–450. 10.1055/s-2007-981279PubMedView ArticleGoogle Scholar
- Tepetes K, Christodoulidis G, Spyridakis EM, Chatzitheofilou C: Tissue preserving hepatectomy by a vessel sealing device. J Surg Oncol 2008,97(2):165–168. 10.1002/jso.20889PubMedView ArticleGoogle Scholar
- Cronjé HS, De Coning EC: Electrosurgical bipolar vessel sealing during vaginal hysterectomy. Int J Gynaecol Obstet. 2005,91(3):243–245. Epub 2005 Oct 21 10.1016/j.ijgo.2005.08.019PubMedView ArticleGoogle Scholar
- Demirturk F, Aytan H, Caliskan AC: Comparison of the use of electrothermal bipolar vessel sealer with harmonic scalpel in total laparoscopic hysterectomy. J Obstet Gynaecol Res 2007,33(3):341–345. 10.1111/j.1447-0756.2007.00533.xPubMedView ArticleGoogle Scholar
- Metzelder ML, Kübler JF, Nustede R, Ure BM: LigaSure in laparoscopic transperitoneal heminephroureterectomy in children: a comparative study. J Laparoendosc Adv Surg Tech A 2006,16(5):522–525. 10.1089/lap.2006.16.522PubMedView ArticleGoogle Scholar
- Santini M, Vicidomini G, Fiorello A, Laperuta P, Busiello L: Electrothermal bipolar tissue sealing systems in lung surgery. MMCTS 2008.,2008(0915): http://mmcts.oxfordjournals.org/content/2008/0915/mmcts.2007.003111.full Google Scholar
- Ponsky TA, Khosla A, Rothenberg SS: Experience with a new energy source for tissue fusion in pediatric patients. J Laparoendosc Adv Surg Tech A. 2009,19(Suppl 1):S207–9.PubMedView ArticleGoogle Scholar
- Janssen PF, Brölmann HA, Huirne JA: Effectiveness of electrothermal bipolar vessel-sealing devices versus other electrothermal and ultrasonic devices for abdominal surgical hemostasis: a systematic review. Surg Endosc 2012,26(10):2892–901. 10.1007/s00464-012-2276-6PubMedView ArticleGoogle Scholar
- Di Lorenzo N, Franceschilli L, Allaix ME, Asimakopoulos AD, Sileri P, Gaspari AL: Radiofrequency versus ultrasonic energy in laparoscopic colorectal surgery: a metaanalysis of operative time and blood loss. Surg Endosc 2012,26(10):2917–24. 10.1007/s00464-012-2285-5PubMedView ArticleGoogle Scholar
- Garas G, Okabayashi K, Ashrafian H, Shetty K, Palazzo F, Tolley N, Darzi A, Athanasiou T, Zacharakis E: Which Hemostatic Device in Thyroid Surgery? A network meta-analysis of surgical technologies. Thyroid 2013,23(9):1138–1150. 10.1089/thy.2012.0588PubMedView ArticleGoogle Scholar
- Sigel B, Dunn MR: The mechanism of blood vessel closure by high frequency electrocoagulation. Surg Gynecol Obstet 1965,121(4):823–31.PubMedGoogle Scholar
- Wallwiener CW, Rajab TK, Zubke W, Isaacson KB, Enderle M, Schäller D, Wallwiener M: Thermal conduction, compression, and electrical current—an evaluation of major parameters of electrosurgical vessel sealing in a porcine in vitro model. J Minim Invasive Gynecol. 2008,15(5):605–10. 10.1016/j.jmig.2008.05.003PubMedView ArticleGoogle Scholar
- Reyes DA, Brown SI, Cochrane L, Motta LS, Cuschieri A: Thermal fusion: effects and interactions of temperature, compression, and duration variables. Surg Endosc 2012,26(12):3626–33. 10.1007/s00464-012-2386-1PubMedView ArticleGoogle Scholar
- Kiriakopoulos A, Dimitrios T, Dimitrios L: Use of a diathermy system in thyroid surgery. Arch Surg 2004,139(9):997–1000. 10.1001/archsurg.139.9.997PubMedView ArticleGoogle Scholar
- Petersen S, Schwenk W: Laparoscopic assisted sigmoid resection for diverticular disease. Langenbecks Arch Surg 2012,397(3):487–90. 10.1007/s00423-011-0891-7PubMedView ArticleGoogle Scholar
- Park CW, Portenier DD: Bipolar electrosurgical devices. In The SAGES Manual on the Fundamental Use of Surgical Energy (FUSE). Edited by: Feldman LS. New York: Springer; 2012:93–106.View ArticleGoogle Scholar
- Newcomb WL, Hope WW, Schmelzer TM, Heath JJ, Norton HJ, Lincourt AE, Heniford BT, Iannitti DA: Comparison of blood vessel sealing among new electrosurgical and ultrasonic devices. Surg Endosc 2009,23(1):90–6. 10.1007/s00464-008-9932-xPubMedView ArticleGoogle Scholar
- Hruby GW, Marruffo FC, Durak E, Collins SM, Pierorazio P, Humphrey PA, Mansukhani MM, Landman J: Evaluation of surgical energy devices for vessel sealing and peripheral energy spread in a porcine model. J Urol 2007,178(6):2689–93. Epub 2007 Oct 22 10.1016/j.juro.2007.07.121PubMedView ArticleGoogle Scholar
- Presthus JB, Brooks PG, Kirchhof N: Vessel sealing using a pulsed bipolar system and open forceps. J Am Assoc Gynecol Laparosc 2003,10(4):528–33. 10.1016/S1074-3804(05)60161-2PubMedView ArticleGoogle Scholar
- Seehofer D, Mogl M, Boas-Knoop S, Unger J, Schirmeier A, Chopra S, Eurich D: Safety and efficacy of new integrated bipolar and ultrasonic scissors compared to conventional laparoscopic 5-mm sealing and cutting instruments. Surg Endosc 2012,26(9):2541–9. 10.1007/s00464-012-2229-0PubMed CentralPubMedView ArticleGoogle Scholar
- Berdah SV, Hoff C, Poornoroozy PH, Razek P, Van Nieuwenhove Y: Postoperative efficacy and safety of vessel sealing: an experimental study on carotid arteries of the pig. Surg Endosc 2012,26(8):2388–93. 10.1007/s00464-012-2177-8PubMedView ArticleGoogle Scholar
- Kennedy JS, Stranahan PL, Taylor KD, Chandler JG: High-burst-strength, feedback-controlled bipolar vessel sealing. Surg Endosc 1998,12(6):876–8. 10.1007/s004649900733PubMedView ArticleGoogle Scholar
- Ikeda M, Hasegawa K, Sano K, Imamura H, Beck Y, Sugawara Y, Kokudo N, Makuuchi M: The vessel sealing system (LigaSure) in hepatic resection: a randomized controlled trial. Ann Surg 2009,250(2):199–203. 10.1097/SLA.0b013e3181a334f9PubMedView ArticleGoogle Scholar
- Uzunoglu FG, Bockhorn M, Fink JA, Reeh M, Vettorazzi E, Gawad KA, Bogoevski D, Vashist YK, Tsui TY, Koenig A, Mann O, Izbicki JR: LigaSure™ vs. conventional dissection techniques in pancreatic surgery–a prospective randomized single-centre trial. J Gastrointest Surg 2013,17(3):494–500. 10.1007/s11605-012-2107-zPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.